@article{2954363,
    title = "Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study",
    author = "Quach, Hang and Fernyhough, Liam and Henderson, Ross and Corbett, Gillian and Baker, Bart and Browett, Peter and Blacklock, Hilary and Forsyth, Cecily and Underhill, Craig and Cannell, Paul and others",
    journal = "British Journal of Haematology",
    year = "2017",
    volume = "177",
    number = "3",
    pages = "441--448",
    issn = "0007-1048, 1365-2141"
}